WOCKHARDT BIO AG FDA Approval ANDA 065420

ANDA 065420

WOCKHARDT BIO AG

FDA Drug Application

Application #065420

Application Sponsors

ANDA 065420WOCKHARDT BIO AG

Marketing Status

Prescription001

Application Products

001FOR SUSPENSION;ORAL600MG/5ML;EQ 42.9MG BASE/5ML0AMOXICILLIN AND CLAVULANATE POTASSIUMAMOXICILLIN; CLAVULANATE POTASSIUM

FDA Submissions

ORIG1AP2013-12-02
LABELING; LabelingSUPPL2AP2016-10-10STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15

TE Codes

001PrescriptionAB

CDER Filings

WOCKHARDT BIO AG
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65420
            [companyName] => WOCKHARDT BIO AG
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMOXICILLIN AND CLAVULANATE POTASSIUM","activeIngredients":"AMOXICILLIN; CLAVULANATE POTASSIUM","strength":"600MG\/5ML;EQ 42.9MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AMOXICILLIN AND CLAVULANATE POTASSIUM","submission":"AMOXICILLIN; CLAVULANATE POTASSIUM","actionType":"600MG\/5ML;EQ 42.9MG BASE\/5ML","submissionClassification":"FOR SUSPENSION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.